USPharmacist | Weekly News Update


April 22, 2015
  • Pharmacists Improve Anticoagulant Adherence for Atrial Fibrillation Patients

    The target-specific oral anticoagulants can be safer and more patient-friendly than warfarin—but only if they are used correctly. Assuring that can be especially difficult when patients no longer receive regular monitoring, as with warfarin. The solution, according to a new study: Let pharmacists do the education and management.

  • Record Number of Prescriptions Filled, Big Increase in Drug Spending

    How crazy busy was last year at the typical pharmacy counter? Very, according to a new study finding that a record-breaking 4.3 billion prescriptions were filled in the United States. Find out how type of insurance affected the number of drugs dispensed.

  • Regulation of Colchicine Lowers Usage,
    Raises Costs

    In a case of good intentions gone astray, fewer patients now take colchicine for gout and other conditions, and those that do are paying as much as 55 times more per pill than in the past. Here’s what a study has to say about the FDA’s decision to regulate the drug 8 years ago and the unintended consequences.

  • Finasteride for Hair Loss Trials Fail to Address
    Sexual Dysfunction

    Trying to answer questions about the safety of finasteride for male hair loss could cause pharmacists to pull their hair out. The reality, according to a new study, is that insufficient information exists to adequately establish the safety of the drug for that condition. Here are the details.

U.S. Pharmacist Social Connect